Royalty Pharma to Announce Second-Quarter 2021 Financial Results on August 11, 2021

Go back to Royalty Pharma to Announce Second-Quarter 2021 Financial Results on August 11, 2021
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 40.21 +0.47 (1.18%)
Previous Close $39.74    52 Week High $3.48 
Open $39.49    52 Week Low $0.80 
Day High $40.32    P/E N/A 
Day Low $39.36    EPS $-1.54 
Volume 1,392,061